<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03737279</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-18-0810</org_study_id>
    <nct_id>NCT03737279</nct_id>
  </id_info>
  <brief_title>Daily Meditation Program in Women Admitted to the Antepartum Unit</brief_title>
  <acronym>Meditate</acronym>
  <official_title>Daily Meditation Program in Women Admitted to the Antepartum Unit: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether a daily mindful meditation program for women
      admitted to the antepartum floor will decrease maternal state anxiety compared to routine
      care.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 4, 2019</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">April 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal state anxiety as assessed by the State Anxiety Scale</measure>
    <time_frame>1-3 days</time_frame>
    <description>The State Anxiety Scale Ranges from 20 to 80, with higher scores indicating a higher anxiety level.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal state anxiety as assessed by the State Anxiety Scale</measure>
    <time_frame>1 to 11 weeks.</time_frame>
    <description>The State Anxiety Scale score ranges from 20 to 80, with higher scores indicating a higher anxiety level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress as assessed by the Perceived Stress Scale</measure>
    <time_frame>3 days to 11 weeks.</time_frame>
    <description>The Perceived Stress Scale score ranges from 0 to 40, with higher scores indicating a higher stress level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression as assessed by the Edinburgh Depression Scale</measure>
    <time_frame>3 days to 11 weeks.</time_frame>
    <description>The Edinburgh Depression Scale score ranges from 0 to 30, with higher scores indicating a higher depression level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>3 days to 11 weeks.</time_frame>
    <description>The Patient satisfaction questionnaire will be scored by a 5-point Likert Scale. Two questions will be asked relating to overall experience with the research trial and overall experience in the hospital. Each of the two questions will be rated with a 5-point Likert, with a total score ranging from 2 to 10 and with higher scores indicating a [better/worse] outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Latency period</measure>
    <time_frame>At delivery.</time_frame>
    <description>Latency period is defined as time from randomization until delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of meditation sessions</measure>
    <time_frame>11 weeks</time_frame>
    <description>Meditation sessions as reported per patient and documented by phone application.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of meditation sessions</measure>
    <time_frame>11 weeks</time_frame>
    <description>Meditation duration as reported per patient and documented by phone application.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Pregnancy, High Risk</condition>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Group:
Routine care plus twice daily mindful meditation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control Group:
Routine care which includes ACOG educational pamphlets on day 1, 2 and 3 after randomization</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Meditation</intervention_name>
    <description>Routine care + twice daily meditation per schedule, to start on the day of randomization</description>
    <arm_group_label>Meditation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Routine Care</intervention_name>
    <description>Routine care including ACOG educational pamphlets:
Day 1: &quot;Nutrition in Pregnancy&quot;
Day 2: &quot;Heart Health for Women&quot;
Day 3: &quot;Exercise after Pregnancy&quot;</description>
    <arm_group_label>Meditation</arm_group_label>
    <arm_group_label>Routine care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 18 years of age

          -  ≥ 23.0 weeks gestation

          -  Planned inpatient care for &gt; 3 days from randomization

          -  Women cared for by UT physicians

        Exclusion Criteria:

          -  Known major lethal fetal anomalies (eg. trisomy 13, trisomy 18, anencephaly, Potter's
             Syndrome)

          -  Non-English speaking women

          -  Planned delivery ≤ 3 days from randomization

          -  Previous fetal surgery in the current pregnancy (twin twin transfusion syndrome laser
             ablation, spina bifida repair, etc)

          -  Women who have practiced a form of meditation in the current pregnancy (including
             yoga) in the last 4 weeks

          -  Women who are currently using patient-controlled analgesia (PCA) (eg. sickle cell
             crisis)

          -  Admission diagnosis of ecclampsia or HELLP (hemolysis, elevated liver enzymes, low
             platelets) syndrome

          -  Diagnosed personality disorder including borderline personality disorder, histrionic
             personality disorder, schizoid personality disorder, schizotypal personality disorder,
             schizophrenia

          -  Diagnosed anxiety, depression, bipolar or other psychiatric illness on medications for
             these disorders

          -  Non-reassuring fetal heart tracing on admission

          -  Intrauterine fetal demise at randomization

          -  Inability to gain access to phone application
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morgen S Doty, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 23, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Morgen Doty</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Meditation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

